- Research works
- 42 ▲ 936% vs 2013–17
- Citations
- 375 9.0 per fractional work
- Top-10% rate
- 14.4% record average 16.5%
- Open access
- 50% world 28%
Not ranked overall: American Thrombosis and Hemostasis Network is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 4.4×. Every wedge is a field page.
Which keywords describe research at American Thrombosis and Hemostasis Network?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Prophylaxis, Gene Therapy, Recombinant Factor VIIa, Factor VIII, Hemophilia, Thrombosis, Inflammation and Hemostasis.
- Risk Factors
- Platelets
- Hemostasis
- Thrombosis
- Factor VIII
- Gene Therapy
- Prophylaxis
- Recombinant Factor VIIa
- Hemophilia
- Inflammation
- Immune Thrombocytopenic Purpura
- Antithrombotic Therapy
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 12 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 12 words, with their numbers
- Prophylaxis8▲ 327×2 topics
- Gene Therapy8▲ 213×2 topics
- Recombinant Factor VIIa8▲ 901×2 topics
- Factor VIII8▲ 2775×1 topic
- Hemophilia8▲ 2775×1 topic
- Thrombosis3▲ 62×4 topics
- Inflammation3▲ 7.8×5 topics
- Hemostasis3▲ 156×4 topics
- Immune Thrombocytopenic Purpura2▲ 393×1 topic
- Platelets2▲ 150×1 topic
- Antithrombotic Therapy1▲ 76×2 topics
- Risk Factors1▲ 5.0×4 topics
Which research topics does American Thrombosis and Hemostasis Network publish most on?
By volume in 2022–2025: Hemophilia Treatment and Research, Platelet Disorders and Treatments, Coagulation, Bradykinin, Polyphosphates, and Angioedema and Blood Coagulation and Thrombosis Mechanisms.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Hemophilia Treatment and Research Hematology 8 works
- 2 Platelet Disorders and Treatments Hematology 2 works
- 3 Coagulation, Bradykinin, Polyphosphates, and Angioedema Genetics 1 works
- 4 Blood Coagulation and Thrombosis Mechanisms Hematology 1 works
- 5 Antiplatelet Therapy and Cardiovascular Diseases Cardiology and Cardiovascular Medicine 1 works
- 6 Blood donation and transfusion practices Management of Technology and Innovation 0 works
- 7 Cancer-related gene regulation Molecular Biology 0 works
- 8 Venous Thromboembolism Diagnosis and Management Internal Medicine 0 works
- 9 Heparin-Induced Thrombocytopenia and Thrombosis Surgery 0 works
- 10 FinTech, Crowdfunding, Digital Finance Management Information Systems 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has American Thrombosis and Hemostasis Network's research output changed?
Output in 2018–2022 was 936% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Chicago
- University of Chicago
- University of Illinois Chicago
- Loyola University Chicago
- Rush University Medical Center
- Illinois Institute of Technology
- DePaul University
- Experimental Station
- Boeing (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.